Min Wu Jie Liu Samuel Seery Xue Meng Jinbo Yue
10.3389/fimmu.2021.646085
Front Immunol
2021 Jun 15;12:646085.
mlr abscopal effect camrelizumab clear cell renal cell carcinoma pseudoprogression
CC BY
https://pubmed.ncbi.nlm.nih.gov/34211459/
Antibodies, Monoclonal, Humanized / therapeutic use Carcinoma, Renal Cell / therapy Cytoreduction Surgical Procedures / methods Kidney Neoplasms / therapy Nephrectomy / methods
Antibodies, Monoclonal, Humanized / therapeutic use Carcinoma, Renal Cell / therapy Cytoreduction Surgical Procedures / methods Kidney Neoplasms / therapy Nephrectomy / methods Case Reports Research Support, Non-U.S. Gov't Review Aged Carcinoma, Renal Cell / immunology Carcinoma, Renal Cell / pathology Combined Modality Therapy Humans Immune Checkpoint Inhibitors / therapeutic use Kidney Neoplasms / immunology Kidney Neoplasms / pathology Lymphocyte Culture Test, Mixed Male Neoplasm Metastasis Radiotherapy Dosage Receptors, Antigen, T-Cell, alpha-beta / physiology Tumor-Associated Macrophages / immunology Antibodies, Monoclonal, Humanized Immune Checkpoint Inhibitors Receptors, Antigen, T-Cell, alpha-beta camrelizumab
PMC8239433
34211459
Cytoreductive Nephrectomy Promoted Abscopal Effect of Camrelizumab Combined With Radiotherapy for Metastatic Renal Cell Carcinoma: A Case Report and Review of the Literature
2021